The use of anticoagulants in patients hospitalised with COVID-19
In this Cochrane Corner, we highlight the main findings of a Cochrane Review by Flumignan et al. entitled ‘Anticoagulants for people hospitalised with COVID‐19’ and discuss the implications of these findings for research and practice in South Africa. In particular, we underscore the need for additio...
Main Authors: | N Gloeck, A Jaca, T Kredo, G Calligaro |
---|---|
Format: | Article |
Language: | English |
Published: |
South African Medical Association
2023-07-01
|
Series: | Southern African Journal of Critical Care |
Subjects: | |
Online Access: | https://samajournals.co.za/index.php/sajcc/article/view/450 |
Similar Items
-
Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01) -
Update on Anticoagulation Strategies in Patients with ECMO—A Narrative Review
by: Ján Šoltés, et al.
Published: (2023-09-01) -
Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing
by: Matthias M. Engelen, et al.
Published: (2022-03-01) -
The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients
by: Reichman-Warmusz Edyta, et al.
Published: (2022-01-01) -
Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors
by: Stephan N.M.C.G. Oliveira, et al.
Published: (2022-10-01)